|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Variability of platelet aggregation in patients with clopidogrel treatment and hip fracture: A retrospective case-control study on 112 patients显示文摘AIM: To identify the rate of non-responders to clopidogrel treatment in hip fracture patients and study how non-responders differ from controls.METHODS: In a retrospective case-control study we included 28 cases of acute proximal femoral fracture with clopidogrel treatment 2011 to 2013. Eighty-four controls from the same time period were included. Data collected included response to clopidogrel measured with multiple electrode aggregometry(MEA), intraoperative bleeding, erythrocyte transfusion, time to surgery and the incidence of adverse events up to 3 mo after surgery. RESULTS: Eight(29%) of the 28 cases were nonresponders. The median intraoperative bleeding was 300 mL(range, 0-1500), and was lower for non-responders(50 m L) but did not reach statistical significance. Erythrocyte transfusions did not differ between responders, non-responders and controls. Forty-five(40%) of 112 patients had adverse events postoperatively but the rate did not differ between patients with and without clopidogrel treatment.CONCLUSION: Almost one-third of patients withclopidogrel treatment and an acute proximal femoral fracture are non-responders to antiplatelet therapy and can be operated without delay. | Anna Clareus Inga Fredriksson Hkan Wallén Max Gordon André Stark Olof Skldenberg | 2015 | World Journal of Orthopedics2015，6，5： | 4 |
| 2 | Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase Ⅲ trial 显示文摘 | Menter A Tyring SK Gordon K | 2008 | J Am Acad Dermatol2008，58，1： | 1 |
| 3 | Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8- tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo (a) pyrene 显示文摘 | Manchester DK Gordon SK Golas CL | 1987 | Cancer Res1987，47，18： | 1 |
| 4 | Adalimumab therapy for moderate to severe psoriasis : a randomized, controlled phase Ⅲ tri- al 显示文摘 | Menter A Tyring SK Gordon K | 2008 | J Am A cad Dermato12008，58，1： | 1 |
| 5 | Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial显示文摘 | Menter A Tyring SK Gordon K | 2008 | J Am Acad Dermato12008，58，1： | 1 |
| 6 | Diaphragmatic e-ventration and gastric volvulus treated by laparoscopic gas-tropexy显示文摘 | Gordon A Wickremesekera SK Bann S | 2012 | ANZ J Surg2012，82，10： | 1 |
| 7 | Adalimumab therapy for mod-erate to severe psoriasis:A randomized,controlled phase IE trial显示文摘 | Menter AjTyring SK Gordon K | 2008 | J Am Acad Deraiatol2008，58，1： | 1 |
| 8 | Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence显示文摘 | Katiyar SK Gordon VR McLaughlin GL | 1994 | Antimicrob Agents Chemother1994，8，9： | 1 |
| 9 | Adalimumab therapy for moderate to severe psoriasis arthritis:a randomized,controllded phase Ⅲ trial显示文摘 | Menter A Tyring SK Gordon K | | 0，，01： | 1 |
| 10 | Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase llI trial显示文摘 | Menter A Tyring SK Gordon K | 2008 | J Am Acad Dermatol2008，58，1： | 1 |
| 11 | Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-sup- pressed growth hormone 显示文摘 | Subbarayan SK Fleseriu M Gordon MB | 2012 | Endocr Pract2012，18，6： | 1 |
| 12 | Serum IGF-1 in thediagnosis of Acromegaly and the Profile of Patients with Elevated IGF-1 but Normal Glucose Suppressed Growth Hormone显示文摘 | Subbaravan SK Fleseriu M Gordon MB | | 0，，06： | 1 |
| 13 | Adalimumab therapy for moderate to severe psoriasis:a randomized,controlled phaseⅢtrial显示文摘 | Menter A Tyring SK Gordon K | 2008 | J Am Acad Dermatol2008，58，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员